Optinose Announces Study Results Of Intranasal Device For Treating Chronic Rhinosinusitis With Nasal Polyps
News-Medical -- OptiNose is pleased to announce the publication of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the topical treatment of chronic rhinosinusitis with nasal polyps in Rhinology, the official journal of the International and European Rhinologic Societies.